Outcomes after 18 months of eliglustat therapy in treatment-naïve adults with Gaucher disease type 1: The phase 3 ENGAGE trial.

Details

Language :

English

ISSN :

03618609

Volume :

92

Issue :

11

Database :

Complementary Index

Journal :

American Journal of Hematology

Publication Type :

Academic Journal

Accession number :

125715663

Full Text :

https://doi.org/10.1002/ajh.24877